Free Trial

Oxford BioMedica (OTCMKTS:OXBDF) Stock Price Down 0.6% - Should You Sell?

Oxford BioMedica logo with Medical background

Key Points

  • Shares of Oxford BioMedica (OTCMKTS:OXBDF) decreased by 0.6% during mid-day trading, dropping from a previous close of $6.30 to $6.26.
  • The company experienced a trading volume of 500 shares, marking an increase of 11% compared to the average session volume of 450 shares.
  • Oxford BioMedica is known for its LentiVector platform technology, which focuses on overcoming safety and delivery challenges in gene therapy.
  • Need better tools to track Oxford BioMedica? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Oxford BioMedica (OTCMKTS:OXBDF - Get Free Report) was down 0.6% during trading on Tuesday . The stock traded as low as $6.08 and last traded at $6.26. Approximately 500 shares traded hands during mid-day trading, an increase of 11% from the average daily volume of 450 shares. The stock had previously closed at $6.30.

Oxford BioMedica Stock Up 7.3%

The company has a 50-day simple moving average of $5.02 and a 200 day simple moving average of $4.43.

About Oxford BioMedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

See Also

Should You Invest $1,000 in Oxford BioMedica Right Now?

Before you consider Oxford BioMedica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.

While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines